ID24524A - Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen - Google Patents

Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen

Info

Publication number
ID24524A
ID24524A IDW20000958A ID20000958A ID24524A ID 24524 A ID24524 A ID 24524A ID W20000958 A IDW20000958 A ID W20000958A ID 20000958 A ID20000958 A ID 20000958A ID 24524 A ID24524 A ID 24524A
Authority
ID
Indonesia
Prior art keywords
reductives
phosphereilase
glicogen
aldosa
obstacles
Prior art date
Application number
IDW20000958A
Other languages
English (en)
Inventor
Banavara Lakshman Mylari
Dennis Jay Hoover
Bernard Hulin
Judith Lee Treadway
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24524A publication Critical patent/ID24524A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
IDW20000958A 1997-11-21 1998-11-02 Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen ID24524A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6636597P 1997-11-21 1997-11-21

Publications (1)

Publication Number Publication Date
ID24524A true ID24524A (id) 2000-07-20

Family

ID=22069038

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000958A ID24524A (id) 1997-11-21 1998-11-02 Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen

Country Status (38)

Country Link
EP (1) EP1032424B9 (id)
JP (1) JP2002504478A (id)
KR (2) KR20010032304A (id)
CN (1) CN1279617A (id)
AP (1) AP911A (id)
AR (1) AR016423A1 (id)
AT (1) ATE205403T1 (id)
AU (1) AU733304B2 (id)
BG (1) BG104435A (id)
BR (1) BR9814698A (id)
CA (1) CA2310069A1 (id)
DE (1) DE69801680T2 (id)
DK (1) DK1032424T3 (id)
DZ (1) DZ2656A1 (id)
EA (1) EA002365B1 (id)
ES (1) ES2161548T3 (id)
GR (1) GR3037071T3 (id)
GT (1) GT199800166A (id)
HR (1) HRP20000327A2 (id)
HU (1) HUP0100272A3 (id)
ID (1) ID24524A (id)
IL (1) IL135713A0 (id)
IS (1) IS5453A (id)
MA (1) MA26568A1 (id)
NO (1) NO20002164L (id)
OA (1) OA11379A (id)
PA (1) PA8462301A1 (id)
PE (1) PE135399A1 (id)
PL (1) PL340643A1 (id)
PT (1) PT1032424E (id)
SK (1) SK7222000A3 (id)
TN (1) TNSN98211A1 (id)
TR (1) TR200001451T2 (id)
UA (1) UA57811C2 (id)
UY (1) UY25258A1 (id)
WO (1) WO1999026659A1 (id)
YU (1) YU30700A (id)
ZA (1) ZA9810636B (id)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2535700A (en) * 1999-02-12 2000-08-29 Novo Nordisk A/S Use of pyrrolidine derivatives for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity or appetite regulation
PT1741447E (pt) 2000-01-21 2013-12-11 Novartis Ag Combinações que compreendem o inibidor da dipeptidilpeptidase-iv
CO5271699A1 (es) 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
US6570013B2 (en) 2000-02-16 2003-05-27 Pfizer Inc Salts of zopolrestat
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
IL144507A0 (en) * 2000-07-31 2002-05-23 Pfizer Prod Inc Use of glycogen phosphorylase inhibitors to inhibit tumor growth
WO2002098429A1 (en) * 2001-06-07 2002-12-12 Pfizer Products Inc. Ethanolamine, diethanolamine or triethanolamine salt of zopolrestat
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US7057046B2 (en) 2002-05-20 2006-06-06 Bristol-Myers Squibb Company Lactam glycogen phosphorylase inhibitors and method of use
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
ES2524916T3 (es) 2003-11-12 2014-12-15 Sino-Med International Alliance, Inc. Compuestos heterocíclicos de ácido borónico
US7317109B2 (en) 2003-11-12 2008-01-08 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7576121B2 (en) 2003-11-12 2009-08-18 Phenomix Corporation Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
CA2573848A1 (en) 2004-07-12 2006-02-16 Phenomix Corporation Constrained cyano compounds
WO2006053274A2 (en) 2004-11-15 2006-05-18 Bristol-Myers Squibb Company 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7226942B2 (en) 2004-11-15 2007-06-05 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7223786B2 (en) 2004-11-15 2007-05-29 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
US7365061B2 (en) 2004-11-15 2008-04-29 Bristol-Myers Squibb Company 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
EP2527337A1 (en) 2005-04-14 2012-11-28 Bristol-Myers Squibb Company Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
US7825139B2 (en) 2005-05-25 2010-11-02 Forest Laboratories Holdings Limited (BM) Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
HRP20140091T4 (hr) 2005-09-14 2021-12-24 Takeda Pharmaceutical Company Limited Davanje inhibitora dipeptidil peptidaze
EP2046753A2 (en) 2006-07-06 2009-04-15 Brystol-Myers Squibb Company Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
US7727978B2 (en) 2006-08-24 2010-06-01 Bristol-Myers Squibb Company Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
JP2010524953A (ja) 2007-04-17 2010-07-22 ブリストル−マイヤーズ スクイブ カンパニー 縮合ヘテロ環１１−β−ヒドロキシステロイドデヒドロゲナーゼＩ型阻害剤
ES2388967T3 (es) 2007-05-04 2012-10-22 Bristol-Myers Squibb Company Agonistas [6,6]- y [6,7]-bicíclicos del receptor GPR119 acoplado a la proteína G
EP2152707B1 (en) 2007-05-04 2012-06-20 Bristol-Myers Squibb Company [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
KR20100051814A (ko) 2007-07-17 2010-05-18 브리스톨-마이어스 스큅 컴퍼니 Ｇｐｒ１１９ ｇ 단백질-커플링된 수용체의 조절 방법 및 선택된 화합물
TW201006821A (en) 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
JP5711270B2 (ja) 2010-02-03 2015-04-30 武田薬品工業株式会社 アポトーシスシグナル調節キナーゼ１阻害剤
EA201270755A1 (ru) 2010-04-08 2013-03-29 Бристол-Майерс Сквибб Компани Аналоги пиримидинилпиперидинилоксипиридинона в качестве модуляторов рецептора gpr119
WO2011130459A1 (en) 2010-04-14 2011-10-20 Bristol-Myers Squibb Company Novel glucokinase activators and methods of using same
WO2011140161A1 (en) 2010-05-06 2011-11-10 Bristol-Myers Squibb Company Benzofuranyl analogues as gpr119 modulators
CA2798610A1 (en) 2010-05-06 2011-11-10 Bristol-Myers Squibb Company Bicyclic heteroaryl compounds as gpr119 modulators
US9566269B2 (en) 2011-01-20 2017-02-14 Bionevia Pharmaceuticals Inc. Modified release compositions of epalrestat or a derivative thereof and methods for using the same
US9174965B2 (en) 2012-05-16 2015-11-03 Bristol-Myers Squibb Company Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators
WO2015061272A1 (en) 2013-10-22 2015-04-30 Bristol-Myers Squibb Company Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
US10604541B2 (en) 2016-07-22 2020-03-31 Bristol-Myers Squibb Company Glucokinase activators and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4825448A (en) * 1986-08-07 1989-04-25 International Mobile Machines Corporation Subscriber unit for wireless digital telephone system
DE3889326D1 (de) * 1988-05-27 1994-06-01 Itt Ind Gmbh Deutsche Korrekturschaltung für ein digitales Quadratur-Signalpaar.
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
AP9600817A0 (en) * 1995-06-06 1996-07-31 Pfizer Novel cryatal form of anhydrous 7-( [1A,5A,6A]-6-amino3-3-azabicyclo [3.1.0.] hex-3-yl) -6-fluro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt.
CA2342471C (en) * 1995-06-06 2002-10-29 Judith L. Treadway Heterocyclecarbonylmethyl amine intermediates

Also Published As

Publication number Publication date
CN1279617A (zh) 2001-01-10
PL340643A1 (en) 2001-02-12
AP9801401A0 (en) 1998-12-31
ATE205403T1 (de) 2001-09-15
ZA9810636B (en) 2000-05-22
EA200000433A1 (ru) 2000-12-25
NO20002164L (no) 2000-07-19
BR9814698A (pt) 2000-10-03
KR20010032300A (ko) 2001-04-16
IL135713A0 (en) 2001-05-20
AR016423A1 (es) 2001-07-04
EP1032424B1 (en) 2001-09-12
OA11379A (en) 2004-01-28
SK7222000A3 (en) 2001-09-11
TNSN98211A1 (fr) 2005-03-15
WO1999026659A1 (en) 1999-06-03
EA002365B1 (ru) 2002-04-25
TR200001451T2 (tr) 2002-06-21
BG104435A (bg) 2001-01-31
GT199800166A (es) 2000-04-19
GR3037071T3 (en) 2002-01-31
CA2310069A1 (en) 1999-06-03
HRP20000327A2 (en) 2001-02-28
EP1032424A1 (en) 2000-09-06
AP911A (en) 2000-12-07
UA57811C2 (uk) 2003-07-15
DZ2656A1 (fr) 2003-03-22
AU9555898A (en) 1999-06-15
JP2002504478A (ja) 2002-02-12
NO20002164D0 (no) 2000-04-27
DE69801680D1 (de) 2001-10-18
UY25258A1 (es) 2000-12-29
HUP0100272A2 (hu) 2001-06-28
PT1032424E (pt) 2001-12-28
PA8462301A1 (es) 2000-05-24
EP1032424B9 (en) 2004-10-06
YU30700A (sh) 2002-12-10
KR20010032304A (ko) 2001-04-16
DK1032424T3 (da) 2001-11-19
KR100661214B1 (ko) 2006-12-26
MA26568A1 (fr) 2004-12-20
ES2161548T3 (es) 2001-12-01
IS5453A (is) 2000-04-14
AU733304B2 (en) 2001-05-10
DE69801680T2 (de) 2002-02-07
HUP0100272A3 (en) 2002-11-28
PE135399A1 (es) 2000-01-15

Similar Documents

Publication Publication Date Title
ID24524A (id) Kombinasi penghambat reduktase aldosa dan penghambat fosforilase glikogen
ID22807A (id) Hasil derifat 1-aril dan piridilpirazol untuk pestisida
ID19422A (id) Piridina dan bifenil tersubstitusi
ID27859A (id) Tampon dan metoda pembuatannya
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID20463A (id) Turunan-turunan penil-dan aminofenil-alkilsulfonamida dan urea
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID28114A (id) Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait
ID19588A (id) Ester dan amida heterosiklik
ID26331A (id) Metode dan sistem untuk pita-pita kelipatan penarik
ID19833A (id) Aralkil dan aralkilidena heterosiklik laktam dan imida
ID22956A (id) Sintesa disulfida dan polisulfida organik
ID19385A (id) Adesif termosetting dan metoda pembuatannya
ID16889A (id) Senyawa turunan alkilaminobenzotiazol dan benzoksazol
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID24695A (id) Metode dan konstruksi basemen anti lembab
ID28025A (id) Metode pembuatan aminonitril dan diamina
ID23258A (id) Penarik pemberian-menyilang dan metodenya
ID24463A (id) Metode meningkatkan ketersediaan hayati feksofenadin dan turunan-turunannya
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID21847A (id) Komposisi insektisida dan metoda penggunaannya
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin